RxDoctor Payments Data

Robert Benigar, MD

Psychiatry · Addison, TXNPI 1750392734

Payments from drug & device makers

$9,630in general payments, 2019–2025

Across 580 payments — averaging $16.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Otsuka America Pharmaceutical, Inc.$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$917
  • Teva Pharmaceuticals USA, Inc.$671
  • Corium, LLC$597
  • Lundbeck LLC$549
  • plus $4K from 31 others

What the payments were for

  • Food & beverage$9,41498%
  • Education$2162%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,630 in reported general payments places this provider in the 90th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$119,029
Medicare patients
68
Services billed
916

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine13$106,260
RexultiBrexpiprazole36$67,543
TrintellixVortioxetine Hydrobromide57$40,360
VraylarCariprazine Hcl15$28,706
AuvelityDextromethorphan Hbr/Bupropion15$18,727
Lisdexamfetamine Dimesylate39$9,327
Desvenlafaxine Succinate ErDesvenlafaxine Succinate115$4,351
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine113$4,187
Clonazepam192$3,517
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine45$3,179
Dexmethylphenidate Hcl ErDexmethylphenidate Hcl20$2,449
Aripiprazole103$2,431
Duloxetine Hcl72$1,925
Vilazodone Hcl23$1,915
Lamotrigine ErLamotrigine20$1,915

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$671$106,26013 claims
Otsuka America Pharmaceutical, Inc.Rexulti$1,079$67,54336 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$344$40,36057 claims
AbbVieVraylar$1,699$28,70615 claims
Axsome Therapeutics, Inc.Auvelity$96$18,72715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Addison

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →